Evidence map›Paper›PMID 37203267›Full record

ArticleHuman molecular genetics2023

Correction to: Dissection of a Down syndrome-associated trisomy to separate the gene dosage-dependent and -independent effects of an extra chromosome.

Abstract readPublished Erratum
In one paragraph

Article in Human molecular genetics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

0 authors.

Funding

Mechanisms of Down syndrome-associated swallowing dysfunction in mouse modelsR01DC019735 · NIDCD · UNIVERSITY OF WISCONSIN-MADISON · PI NADINE P CONNOR, Tiffany Glass · 2022 to 2026
$3.4M
Generation and analysis of new mouse models to determine novel therapeutic targets for Down syndrome-associated cognitive deficitsR01HD109750 · NICHD · ROSWELL PARK CANCER INSTITUTE CORP · PI Eugene Yu · 2022 to 2026
$3.3M
Mutational analysis to understand the role of CHML in developmental regressionR21GM114645 · NIGMS · ROSWELL PARK CANCER INSTITUTE CORP · PI YU, EUGENE · 2015 to 2016
$474k
European Research CouncilNICHD NIH HHS R01 HD109750NIGMS NIH HHS R21 GM114645Swiss National Science Foundation PZ00P3_174018
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37203267
PMCPMC10505453

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.